PURPOSE: Myelofibrosis with myeloid metaplasia (MMM) is a chronic myeloproliferative disorder characterized by bone marrow fibrosis and extramedullary hematopoiesis. Recent studies provide definite ...

Myelofibrosis belongs to a group of rare diseases called myeloproliferative neoplasms, which are types of blood cancer. These neoplasms can progress to acute myeloid leukemia (AML). In ...

Myeloproliferative neoplasms, such as polycythemia vera, essential thrombocythemia, and myelofibrosis, are chronic hematologic cancers with varied progression rates. The genomic characterization of ...

Promising Biomarker Reductions: Treatment with the MDM2 inhibitor navtemadlin led to significant reductions in key biomarkers of disease severity, including circulating CD34+ cells, a hallmark of ...

Cytopenia in myelofibrosis patients increases the risk of AML progression and decreases overall survival, necessitating careful treatment selection. A retrospective cohort study found 70% of ...

Traditional treatments for Myelofibrosis (MF) aim to address the symptoms, treat related anemia, and reduce your spleen. Complementary therapies may also help. MF is a rare type of cancer where a ...

MOMENTUM was a phase III, global, multicentre, randomised, double-blind study investigating momelotinib versus danazol in patients with myelofibrosis who were symptomatic and anemic and had been ...

Maintaining a balanced diet is important for people with myelofibrosis as proper nutrition can help support energy levels, immune function, and more. Myelofibrosis is a rare blood cancer that’s part ...